SAFETY

You have access
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation
Marco Sebastiani, Gemma Lepri, Claudia Iannone, Emanuele Bozzalla Cassione, Giuliana Guggino, Andrea lo Monaco, Roberta Foti, Marco Fornaro, Maria Sole Chimenti, Angelo Fassio, Simona Truglia, Francesca Cozzini, Antonio Carletto, Alessandro Giollo, Addolorata Corrado, Chiara Bazzani, Serena Guiducci, Ennio Favalli, Serena Bugatti, Florenzo Iannone, Roberto Caporali and Andreina Manfredi

The Journal of Rheumatology May 1 2025, 52 (5) 420-425; DOI: https://doi.org/10.3899/jrheum.2024-0976
You have access
Patients With Psoriatic Arthritis–Related Enthesitis and Persistence on Tofacitinib Under Real-World Conditions
Ignacio Braña, Marta Loredo, Estefanía Pardo, Stefanie Burger, Eva Fernández-Bretón and Rubén Queiro

The Journal of Rheumatology July 1 2024, 51 (7) 682-686; DOI: https://doi.org/10.3899/jrheum.2024-0016
Open Access
Safety and Healthcare Use Following COVID-19 Vaccination Among Adults With Rheumatoid Arthritis: A Population-Based Self-Controlled Case Series Analysis
Jennifer J.Y. Lee, Sasha Bernatsky, Jeffrey C. Kwong, Qing Li, Timothy S.H. Kwok and Jessica Widdifield

The Journal of Rheumatology January 1 2024, 51 (1) 88-95; DOI: https://doi.org/10.3899/jrheum.2023-0355
You have access
Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study
Marco Lanzillotta, Nicola Boffini, Elisa Barone, Gilberto Cincinelli, Maria C. Gerardi, Nicoletta Luciano, Maria Manara, Nicola Ughi, Oscar M. Epis, Carlo Selmi, Roberto F. Caporali and Lorenzo Dagna

The Journal of Rheumatology December 1 2023, 50 (12) 1581-1586; DOI: https://doi.org/10.3899/jrheum.2023-0145
Open Access
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis
Proton Rahman, Wolf-Henning Boehncke, Philip J. Mease, Alice B. Gottlieb, Iain B. McInnes, May Shawi, Yanli Wang, Shihong Sheng, Alexa P. Kollmeier, Elke Theander, Jenny Yu, Evan Leibowitz, A. Marilise Marrache and Laura C. Coates

The Journal of Rheumatology June 1 2023, 50 (6) 769-780; DOI: https://doi.org/10.3899/jrheum.220928
You have access
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center
Onorina Berardicurti, Viktoriya Pavlych, Ilenia Di Cola, Piero Ruscitti, Paola Di Benedetto, Luca Navarini, Annalisa Marino, Paola Cipriani and Roberto Giacomelli

The Journal of Rheumatology February 1 2022, 49 (2) 171-175; DOI: https://doi.org/10.3899/jrheum.210441
Open Access
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
Proton Rahman, Christopher T. Ritchlin, Philip S. Helliwell, Wolf-Henning Boehncke, Philip J. Mease, Alice B. Gottlieb, Shelly Kafka, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie L. Xu, May Shawi, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Paraneedharan Ramachandran, Yanli Zhuang and Iain B. McInnes

The Journal of Rheumatology December 1 2021, 48 (12) 1815-1823; DOI: https://doi.org/10.3899/jrheum.201532
You have access
Outcomes and Safety of Tumor Necrosis Factor Inhibitors in Reactive Arthritis: A Nationwide Experience from Iceland
Bjarni Thorsteinsson, Arni J. Geirsson, Niels S. Krogh and Bjorn Gudbjornsson on behalf of ICEBIO

The Journal of Rheumatology October 1 2020, 47 (10) 1575-1581; DOI: https://doi.org/10.3899/jrheum.191307
You have access
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials
Louise Klokker, Dorthe B. Berthelsen, Thasia Woodworth, Kathleen M. Andersen, Daniel E. Furst, Dan Devoe, Paula R. Williamson, Maria E. Suarez-Almazor, Vibeke Strand, Amye L. Leong, Niti Goel, Maarten Boers, Peter M. Brooks, Lyn March, Victor S. Sloan, Peter Tugwell, Lee S. Simon and Robin Christensen

The Journal of Rheumatology September 1 2019, 46 (9) 1173-1178; DOI: https://doi.org/10.3899/jrheum.190196
Open Access
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
Josef S. Smolen, Mark C. Genovese, Tsutomu Takeuchi, David L. Hyslop, William L. Macias, Terence Rooney, Lei Chen, Christina L. Dickson, Jennifer Riddle Camp, Tracy E. Cardillo, Taeko Ishii and Kevin L. Winthrop

The Journal of Rheumatology January 1 2019, 46 (1) 7-18; DOI: https://doi.org/10.3899/jrheum.171361

Main menu

User menu

Search

SAFETY

Pages

Content

Resources

Subscribers

More